← litmanintelligence.com  |  ← Counsel PDFs index  |  Counsel dashboard

Patent Revenue Linkage Summary

Patent Revenue Linkage Analysis

Generated: 2026-03-26 21:15 Case: Litman v. Goldberg, Index No. 524343/2025 Purpose: Demonstrate that per-patent revenue attribution is impossible, supporting "entire client relationship revenue" damages theory under NY CRL ss 51.

Executive Summary

Of 906 patents bearing Richard Litman's name issued since June 15, 2020 (the statute of limitations cutoff):

CONCLUSION: Per-patent damages calculation is impossible for 98.0% of patents. Damages must be measured by the entire client relationship revenue stream.

Damages Comparison

Path A: Per-Patent (What Goldberg Wants)

Metric Value
Patents with any financial link 18
Linked revenue (billed) $142,404.00
Linked Litman 20% share $28,480.80
Problem: 888 patents (98.0%) have ZERO linkable revenue

Path B: Entire Relationship Revenue (What Litman Seeks)

Metric Value
Period June 15, 2020 - May 31, 2025
Total funds received under Litman's name $22,096,827.00
Total collected fees $16,175,686.00
Litman's 20% share owed $3,235,137.00
Total paid to Litman $2,730,409 †
Shortfall (underpayment) $504,728
Adjusted Total Paid (cash-only) ~$2,440,409
Adjusted Shortfall (cash-only) ~$794,728

† Includes $290,000 in MetLife long-term-disability offset entries that the arbitrator ruled were improper deductions by NGM. Litman did not receive that $290,000 as cash; it was a paper-offset bookkeeping construct. Adjusted figures (subtracting the $290K offset from "Paid" and adding it to the outstanding balance) are shown in the corresponding reading note. See output/LITMAN_SUMMARY_DISABILITY_OFFSET_EXTRACT_20260416.md and output/RCL_VARIANCE_RECONCILIATION_2020_ANALYSIS_20260416.md for the primary-ledger reconciliation.

Why Path B Prevails

  1. Goldberg's own records don't track per-patent revenue — billing is by docket, and 886 of 905 patents lack any docket mapping in available data.
  2. The 905-patent dataset has no docket numbers — it was sourced from USPTO public records which do not include law firm internal billing codes.
  3. Even the 19 patents with known dockets only link to KFU/KSU/KISR/UAEU reconciliation data — a fraction of total revenue.
  4. Under NY CRL ss 51, damages are measured by the value of the use — Litman's name and professional identity generated ALL the revenue, not just the revenue from specific patents.
  5. Each patent is a separate "use" under the deck-of-cards theory, but the damages from each use encompass the full commercial relationship.

Revenue by Year (All Revenue Under Litman's Name)

Year Total Funds Received Collected Fees
2020 $2,325,950.92 $1,653,523.16
2021 $2,567,833.58 $1,821,985.10
2022 $3,508,415.75 $2,642,939.71
2023 $7,390,354.18 $5,512,122.61
2024 $6,002,737.52 $4,401,418.87
2025_thru_may $1,301,535.48 $943,696.15

Per-Client Breakdown

Client Patents With Docket Linked Family Match Unlinked Linked Revenue
UNKNOWN 888 0 0 0 888 $0.00
KFU 13 13 13 0 0 $142,404.00
KSU 2 2 2 0 0 $0.00
KISR 1 1 1 0 0 $0.00
KNPC 1 1 1 0 0 $0.00
UAEU 1 1 1 0 0 $0.00

Linked Patents Detail

The following patents successfully linked to financial records:

Patent Docket Assignee Billed Collected Litman 20% Source
12194434 33056.80A KSU $4,030.00 $0.00 $0.00 reconciliation_base
12157086 33060.73U KNPC $0.00 $0.00 $0.00 payments_exact
12116333 33150.71A KFU $8,360.00 $8,360.00 $1,672.00 reconciliation_exact
12114620 32366.97U KISR $0.00 $0.00 $0.00 payments_exact
D1046141 33056.38 KSU $0.00 $0.00 $0.00 payments_exact
12071437 33150.41U KFU $13,000.00 $13,000.00 $2,600.00 reconciliation_exact
12065424 33175.60A KFU $3,480.00 $3,480.00 $696.00 reconciliation_exact
12062780 33160.59U KFU $12,760.00 $12,760.00 $2,552.00 reconciliation_exact
12054460 33170.94A KFU $5,000.00 $5,000.00 $1,000.00 reconciliation_exact
12054464 33175.68A KFU $3,480.00 $3,480.00 $696.00 reconciliation_exact
12049459 33120.88U KFU $15,160.00 $15,160.00 $3,032.00 reconciliation_exact
12043608 33120.91U KFU $17,400.00 $17,400.00 $3,480.00 reconciliation_exact
12043609 33130.47U KFU $15,800.00 $15,800.00 $3,160.00 reconciliation_exact
11980937 33150.15U KFU $3,560.00 $3,560.00 $712.00 reconciliation_exact
11976365 33101.73U KFU $21,044.00 $18,644.00 $3,728.80 reconciliation_exact
11932607 33135.26U KFU $12,360.00 $12,360.00 $2,472.00 reconciliation_exact
11881807 33110.68U KFU $15,800.00 $13,400.00 $2,680.00 reconciliation_exact
11814309 33090.24U UAEU $0.00 $0.00 $0.00 trust_exact

Methodology

Data Sources

  1. 905-patent backbone: USPTO PatentsView query, patents listing Litman as attorney since 6/15/2020
  2. patent_app_mapping.csv: 19 patents manually mapped to docket numbers via USPTO IFW documents
  3. KFU/KSU Reconciliation: 3,154-line billing reconciliation from Goldberg's records (June 2025)
  4. Payments history: 205,632-line payment ledger (July 2023 - May 2025)
  5. Trust ledger: 27,898-line trust account ledger
  6. Year-by-year revenue: From Goldberg's Quarterly Compensation Summaries

Matching Strategy

  1. Exact docket match in KFU/KSU reconciliation
  2. Base docket match (strip suffix letter) in reconciliation
  3. Exact/base docket match in payments ledger
  4. Exact docket match in trust ledger
  5. Family-level match (top-level number) in reconciliation

Key Finding

888 of 906 patents in the CN-37833 attorney-record backbone (98.0%) have no docket number at all. The 905-patent dataset sourced from USPTO public records contains only patent number, title, inventors, and issue date — no internal firm billing codes. Without docket numbers, there is NO WAY to connect a specific patent to a specific dollar amount.

This is not a failure of analysis — it reflects the fundamental structure of the data. Goldberg's firm billed by docket number, but USPTO public records do not include docket numbers. The bridge between the two systems exists only for the 19 patents where we obtained USPTO IFW (Image File Wrapper) documents that contained the firm's internal docket reference.


This analysis supports the damages theory in Litman v. Goldberg, Index No. 524343/2025. Every dollar of revenue collected under Litman's name is attributable to the unauthorized use of that name, regardless of whether it can be traced to a specific patent.